Home - Products - Others - Other Targets - γ2-MSH(41-58)|GAMMA-MELANOCYTE STIMULATING HORMONE

γ2-MSH(41-58)|GAMMA-MELANOCYTE STIMULATING HORMONE

CAS No. 72711-43-4

γ2-MSH(41-58)|GAMMA-MELANOCYTE STIMULATING HORMONE( ——— )

Catalog No. M40271 CAS No. 72711-43-4

γ2-MSH(41-58)|GAMMA-MELANOCYTE STIMULATING HORMONE

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    γ2-MSH(41-58)|GAMMA-MELANOCYTE STIMULATING HORMONE
  • Note
    Research use only, not for human use.
  • Brief Description
    γ2-MSH(41-58)|GAMMA-MELANOCYTE STIMULATING HORMONE
  • Description
    γ2-MSH(41-58)|GAMMA-MELANOCYTE STIMULATING HORMONE
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    72711-43-4
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • LTX-315

    LTX-315 (Oncopore) is a synthetic 9-mer anticancer peptide that preferentially permeabilizes mitochondrial membranes.

  • Kisspeptin-13 (human...

    Kisspeptin 13 inhibits glucose-induced insulin secretion with an IC50 of 1.2 nM. Kisspeptin 13 activates the hypothalamic-pituitary-adrenal (HPA) axis, causes hyperthermia, motor behavior and anxiety in rats. Kisspeptin 13 interacts with α2-adrenergic and 5-HT2 serotonin receptors, exhibits antidepressant efficacy. Kisspeptin 13 is an activator for GPR54 and GnRH receptor, which enhances memory and can be used in Alzheimer's disease research.

  • NIC3

    NIC3 is a selective nucleus accumbens-associated protein-1 (NAC1) inhibitor, with anti-cancer activity.